Listed by the American College of Gastroenterology (ACG) Clinical Guideline [5] as a first-line option, Talicia ® is the leading branded H. pylori therapy prescribed by U.S. gastroenterologists ...

First quarter 2025 results presentations were the first chance analysts have had to quiz pharma companies in public about their exposure to the threat of U.S. import tariffs and what action they are ...

Nxera Pharma is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. We have built an agile ...

RALEIGH, N.C., May 2, 2025 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its support of an independent ...

Nxera Pharma is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. We have built an agile, ...

Visit a quote page and your recently viewed tickers will be displayed here. Cost of Goods Sold (COGS) incl. D&A Cost of Goods Sold (COGS) incl. D&A ...

Now it’s at $568, and that’s after 6.87% beating today. Regeneron is arguably the most innovative biopharma company I’ve seen in the last two decades. But the stock’s come in significantly ...

In its latest earnings release, BridgeBio Pharma, Inc. (NASDAQ:BBIO) said that its heart treatment Attruby was gaining traction with 2,072 prescriptions written by 756 prescribers as of April 25 ...

Shinya Tsuzuki, Head of Investor Relations at Nxera, added: “I am excited to join Nxera during this period of evolution to becoming a next-generation biopharma business. I look forward to ...